<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34006386</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-108X</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Trends in neurosciences</Title><ISOAbbreviation>Trends Neurosci</ISOAbbreviation></Journal><ArticleTitle>Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>658</StartPage><EndPage>668</EndPage><MedlinePgn>658-668</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tins.2021.04.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-2236(21)00080-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common adult-onset paralytic disorder, characterized mainly by a loss of motor neurons (MNs) in the CNS. Over the past decades, thanks to intense investigations performed in both in vivo and in vitro models of ALS, major progress has been made toward gaining insights into the pathobiology of this incurable, fatal disorder. Among these advances is the growing recognition that non-neuronal cells participate in the degeneration of MNs in ALS, which could transform our understanding of the neurobiology of disease and the ability to devise effective disease-modifying therapies. In this review, we examine the contribution of non-cell-autonomous processes to the pathogenesis of ALS, with a focus on glial cells and in particular on astrocytes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Harten</LastName><ForeName>Alexandra C M</ForeName><Initials>ACM</Initials><AffiliationInfo><Affiliation>Graduate School of Life and Earth Sciences, University of Amsterdam, Science Park 904, 1090 GE Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phatnani</LastName><ForeName>Hemali</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Medical Center, New York, NY, USA; Center for Motor Neuron Biology and Diseases, Columbia University Medical Center, New York, NY, USA; Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Przedborski</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Medical Center, New York, NY, USA; Center for Motor Neuron Biology and Diseases, Columbia University Medical Center, New York, NY, USA; Departments of Pathology and Cell Biology and Neuroscience, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: sp30@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS116350</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS117583</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS107442</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG064596</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1 HG011014</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS118570</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS118183</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS111176</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066831</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Neurosci</MedlineTA><NlmUniqueID>7808616</NlmUniqueID><ISSNLinking>0166-2236</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">non-cell autonomous</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no interests in relation to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34006386</ArticleId><ArticleId IdType="mid">NIHMS1791778</ArticleId><ArticleId IdType="pmc">PMC8972039</ArticleId><ArticleId IdType="doi">10.1016/j.tins.2021.04.008</ArticleId><ArticleId IdType="pii">S0166-2236(21)00080-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP et al. (2010) Amyotrophic lateral sclerosis, progressive muscular atrophy and primary lateral sclerosis. In Merritt&#x2019;s Neurology (12th edn) (Rowland LP and Pedley TA, eds), pp. 802&#x2013;808, Lippincott Williams &amp; Wilkins</Citation></Reference><Reference><Citation>Chia R et al. (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17, 94&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G et al. (2020) ALS genetics: gains, losses, and implications for future therapies. Neuron 108, 822&#x2013;842</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ and Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol 85, 94&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM et al. (2014) Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J. Neurosci 34, 15587&#x2013;15600</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298650</ArticleId><ArticleId IdType="pubmed">25411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH et al. (2011) Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G93A transgenic ALS mice. J. Neurosci 31, 4166&#x2013;4177</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J et al. (2007) Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci. Lett 420, 128&#x2013;132</Citation><ArticleIdList><ArticleId IdType="pubmed">17543992</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X et al. (2009) Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS. Neurosci. Lett 458, 70&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">19379791</ArticleId></ArticleIdList></Reference><Reference><Citation>Garden GA and La Spada AR (2012) Intercellular (mis) communication in neurodegenerative disease. Neuron 73, 886&#x2013;901</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3334539</ArticleId><ArticleId IdType="pubmed">22405200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J et al. (2014) TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71, 449&#x2013;453</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4087113</ArticleId><ArticleId IdType="pubmed">24535663</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S et al. (2021) Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types. Sci. Adv 7, eabd9036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810371</ArticleId><ArticleId IdType="pubmed">33523907</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR and Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18, 211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113&#x2013;117</Citation><ArticleIdList><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostic V et al. (1997) Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559&#x2013;562</Citation><ArticleIdList><ArticleId IdType="pubmed">9228005</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A et al. (2001) Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci 21, 3369&#x2013;3374</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762496</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D et al. (2008) Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J. Neurosci 28, 2075&#x2013;2088</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671838</ArticleId><ArticleId IdType="pubmed">18305242</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389&#x2013;1392</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C and Petrucelli L (2019) Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron 101, 1057&#x2013;1069</Citation><ArticleIdList><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Schon EA and Przedborski S (2011) Mitochondria: the next (neurode)generation. Neuron 70, 1033&#x2013;1053</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3407575</ArticleId><ArticleId IdType="pubmed">21689593</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP et al. (2016) Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler JP et al. (2016) The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol 26, 227&#x2013;236</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Towne C et al. (2008) Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol. Ther 16, 1018&#x2013;1025</Citation><ArticleIdList><ArticleId IdType="pubmed">18414477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G et al. (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8, 425&#x2013;436</Citation><ArticleIdList><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ and Wong M (2020) Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-like syndrome. Front. Neurol 11, 592851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7767933</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE and Patani R (2020) The microglial component of amyotrophic lateral sclerosis. Brain 143, 3526&#x2013;3539</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T et al. (2013) Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 136, 471&#x2013;482</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S et al. (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L et al. (2011) Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet 20, 286&#x2013;293</Citation><ArticleIdList><ArticleId IdType="pubmed">20962037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci 11, 251&#x2013;253</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR et al. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A 103, 16021&#x2013;16026</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH et al. (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci 16, 571&#x2013;579</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS et al. (2009) Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc. Natl. Acad. Sci. U. S. A 106, 4465&#x2013;4470</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2657393</ArticleId><ArticleId IdType="pubmed">19251638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A et al. (2020) Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat. Neurosci 23, 1339&#x2013;1351</Citation><ArticleIdList><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME et al. (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol 41, 210&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. U. S. A 91, 8292&#x2013;8296</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward LJ et al. (2002) Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem 277, 15923&#x2013;15931</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M et al. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci 10, 615&#x2013;622</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P et al. (2011) Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A 108, 18126&#x2013;18131</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP et al. (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci 10, 608&#x2013;614</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto MC et al. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito LH et al. (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev 47, 263&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">15572176</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz E et al. (2013) Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J. Neurophysiol 109, 2803&#x2013;2814</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680799</ArticleId><ArticleId IdType="pubmed">23486205</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M et al. (2004) Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem 89, 464&#x2013;473</Citation><ArticleIdList><ArticleId IdType="pubmed">15056289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M et al. (2005) Complexity of astrocyte&#x2013;motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener. Dis 2, 139&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">16909019</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadeas ST et al. (2011) Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc. Natl. Acad. Sci. U. S. A 108, 17803&#x2013;17808</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203804</ArticleId><ArticleId IdType="pubmed">21969586</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP et al. (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637&#x2013;648</Citation><ArticleIdList><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM et al. (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol 29, 824&#x2013;828</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB et al. (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81, 1001&#x2013;1008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C et al. (2020) Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia 68, 1046&#x2013;1064</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A et al. (2013) Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. U. S. A 110, 4697&#x2013;4702</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE et al. (2017) Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep 19, 1739&#x2013;1749</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanning KC et al. (2010) Motor neuron diversity in development and disease. Annu. Rev. Neurosci 33, 409&#x2013;440</Citation><ArticleIdList><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N et al. (2018) NF-&#x3ba;B activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J 37, e98697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW and Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci 2, 806&#x2013;819</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443&#x2013;448</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum B et al. (2017) Wildtype motoneurons, ALS-linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia 65, 592&#x2013;605</Citation><ArticleIdList><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton SK et al. (2020) Mutant TDP-43 expression triggers TDP-43 pathology and cell autonomous effects on primary astrocytes: implications for non-cell autonomous pathology in ALS. Neurochem. Res 45, 1451&#x2013;1459</Citation><ArticleIdList><ArticleId IdType="pubmed">32410044</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani HP et al. (2013) Intricate interplay between astrocytes and motor neurons in ALS. Proc. Natl. Acad. Sci. U. S. A 110, E756&#x2013;E765</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581928</ArticleId><ArticleId IdType="pubmed">23388633</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE et al. (2017) A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun 8, 1164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohm L and Behrends C (2020) Glia-specific autophagy dysfunction in ALS. Semin. Cell Dev. Biol 99, 172&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pubmed">31132469</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q et al. (2007) Mutant SOD1G93A microglia are more neurotoxic relative to wild-type microglia. J. Neurochem 102, 2008&#x2013;2019</Citation><ArticleIdList><ArticleId IdType="pubmed">17555556</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P et al. (2004) Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 48, 179&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pubmed">15378658</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME et al. (2020) C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585, 96&#x2013;101</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG et al. (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324&#x2013;1329</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE et al. (2014) Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron 81, 1009&#x2013;1023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W et al. (2015) TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp. Neurol 273, 24&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallardo G et al. (2014) An &#x3b1;2-Na/K ATPase/&#x3b1;-adducin complex in astrocytes triggers non-cell autonomous neurodegeneration. Nat. Neurosci 17, 1710&#x2013;1719</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703324</ArticleId><ArticleId IdType="pubmed">25344630</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA et al. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA et al. (2020) Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun 11, 3753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikiz B et al. (2015) The regulatory machinery of neurodegeneration in in vitro models of amyotrophic lateral sclerosis. Cell Rep 12, 335&#x2013;345</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646662</ArticleId><ArticleId IdType="pubmed">26146077</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K et al. (2020) Mitigation of ALS pathology by neuron-specific inhibition of nuclear factor kappa B signaling. J. Neurosci 40, 5137&#x2013;5154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314413</ArticleId><ArticleId IdType="pubmed">32457070</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V et al. (2020) Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nat. Commun 11, 5579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M et al. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335&#x2013;339</Citation><ArticleIdList><ArticleId IdType="pubmed">10764647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermentzaki G et al. (2019) Deletion of Ripk3 prevents motor neuron death in vitro bu not in vivo. eNeuro 6 ENEURO. 0308&#x2013;18.2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6391588</ArticleId><ArticleId IdType="pubmed">30815534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T et al. (2020) Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death Differ 27, 1728&#x2013;1739</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206015</ArticleId><ArticleId IdType="pubmed">31745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez S et al. (2020) Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS. Cell Death Differ 28, 915&#x2013;931</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937687</ArticleId><ArticleId IdType="pubmed">32994544</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M et al. (2019) Microglia biology: one century of evolving concepts. Cell 179, 292&#x2013;311</Citation><ArticleIdList><ArticleId IdType="pubmed">31585077</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM et al. (2013) A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep 4, 385&#x2013;401</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G et al. (2013) Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Brain 136, 3305&#x2013;3332</Citation><ArticleIdList><ArticleId IdType="pubmed">24065725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH et al. (2019) Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep 29, 1164&#x2013;1177.e5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O et al. (2020) Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm 7, e829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H et al. (2017) A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell 169, 1276&#x2013;1290.e17</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W et al. (2020) Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis. Neurobiol. Dis 141, 104877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519882</ArticleId><ArticleId IdType="pubmed">32360664</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S et al. (2019) Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364, 89&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong Y et al. (2021) Ultrasensitive single-cell proteomics workflow identifies &gt;1000 protein groups per mammalian cell. Chem. Sci 12, 1001&#x2013;1006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178986</ArticleId><ArticleId IdType="pubmed">34163866</ArticleId></ArticleIdList></Reference><Reference><Citation>Specht H et al. (2021) Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2. Genome Biol 22, 50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839219</ArticleId><ArticleId IdType="pubmed">33504367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamby ME et al. (2012) Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors. J. Neurosci 32, 14489&#x2013;14510</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3518872</ArticleId><ArticleId IdType="pubmed">23077035</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanders KC et al. (1998) Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol 54, 71&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">9460794</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P et al. (2017) Reactive astrocytes promote ALS-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-&#x3b2;1. Stem Cell Rep 9, 667&#x2013;680</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V et al. (2020) The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice. Neuron 106, 789&#x2013;805.e5</Citation><ArticleIdList><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A et al. (2014) Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81, 333&#x2013;348</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>